Free Trial

Henry Schein, Inc. (NASDAQ:HSIC) Position Trimmed by Assenagon Asset Management S.A.

Henry Schein logo with Medical background

Assenagon Asset Management S.A. reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 92.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,977 shares of the company's stock after selling 214,706 shares during the period. Assenagon Asset Management S.A.'s holdings in Henry Schein were worth $1,163,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. SG Americas Securities LLC acquired a new position in shares of Henry Schein during the 1st quarter worth approximately $21,551,000. GAMMA Investing LLC raised its position in shares of Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock worth $270,000 after purchasing an additional 1,081 shares during the last quarter. Farther Finance Advisors LLC raised its position in shares of Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after purchasing an additional 1,898 shares during the last quarter. UMB Bank n.a. raised its position in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares during the last quarter. Finally, City State Bank raised its position in shares of Henry Schein by 115.6% during the 1st quarter. City State Bank now owns 1,725 shares of the company's stock worth $118,000 after purchasing an additional 925 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on HSIC. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. UBS Group cut their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Wells Fargo & Company cut their price target on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Barrington Research cut their price target on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Finally, Piper Sandler cut their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a report on Wednesday, April 30th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Henry Schein currently has a consensus rating of "Moderate Buy" and a consensus target price of $79.30.

View Our Latest Stock Report on HSIC

Henry Schein Stock Up 1.2%

Shares of Henry Schein stock traded up $0.85 during trading on Friday, reaching $71.98. The company had a trading volume of 3,332,828 shares, compared to its average volume of 1,707,238. The company has a market cap of $8.76 billion, a price-to-earnings ratio of 22.49, a price-to-earnings-growth ratio of 2.32 and a beta of 0.86. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm's fifty day moving average is $68.94 and its 200-day moving average is $71.25. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. Henry Schein's quarterly revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.10 earnings per share. On average, analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines